Claveau J-S, LeBlanc R, Ahmad I, Delisle J-S, Cohen S, Kiss T, Bambace NM, Bernard L, Lachance S, Roy DClaude, et al. Bortezomib maintenance after allogeneic transplantation in newly diagnosed myeloma patients results in decreased incidence and severity of chronic GVHD. Transplant Cell Ther. 2022.